ERBB2 and occult macular dystrophy: In the RENAISSANCE trial14 , patients with genuine OMD receive four cycles of 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy alone or with trastuzumab if they are positive for human epidermal growth factor receptor 2 (HER2).